2026 is shaping up to be a pivotal year for pharmacy benefits. Rising drug costs and shifting policy priorities are creating both challenges and opportunities for benefit leaders. To stay competitive, it’s not enough to react – you need to anticipate what’s coming.
During this webinar, Truveris experts will unpack trends that will define the year ahead and what they mean for your strategy. We’ll explore the expanding GLP-1 market, biosimilar trends, the 2026 drug pipeline, emerging policy changes that could reshape PBM dynamics, and the growing influence of direct-to-consumer pharmacy models.
Beyond identifying what’s new, we’ll share practical steps to help you manage cost pressures, improve transparency, and align your plan design with evolving member needs.
Learning Objectives:
- Understand the Key Pharmacy Trends for 2026 – Explore the most influential developments shaping the pharmacy benefits landscape, including the expanding GLP-1 market, biosimilars, anticipated policy changes, and the rise of direct-to-consumer pharmacy models.
- Translate Trends into Strategy – Learn how these emerging dynamics will impact plan design and discover practical steps to optimize pharmacy benefit strategies for cost control, member engagement, and organizational goals.
About the Speakers:
Brooke Henry, PharmD, Clinical Director
As a pharmacist with over 13 years of experience in pharmacy benefit management, including more than a decade in leadership roles, Brooke Henry is a results-driven healthcare professional dedicated to improving patient outcomes and client satisfaction. At Truveris, she provides clinical expertise and pharmacy benefits decision support for clients.
Anthony Ianacci, Director of Strategic Solutions
Anthony Iannaci has spent the last seven years at Truveris evaluating hundreds of PBM contracts while also using robust data and analytics to pair PBMs and pharmacy vendors with plan sponsors, creating the most efficient, mutually beneficial partnerships possible. Before joining Truveris, Anthony served as an internal consultant at GLO Science, a high-growth oral health device company.
Kylie Harris, Insights Senior Analyst
Kylie Harris is an Insights Senior Analyst at Truveris, where she has spent the past three years helping clients navigate complex healthcare data to drive strategic decisions. Prior to joining Truveris, Kylie worked in drug development research.
Truveris is a leading digital health company focused on delivering truth and clarity in pharmacy. Truveris’ proprietary technology, coupled with deep pharmacy expertise, helps to build a more efficient market that maximizes choice, accessibility, and prescription drug affordability. Our solutions provide the insight and knowledge to help people lead healthier and more productive lives.
